ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990

In Brief: Rhode Island, Los Angeles Approved For NCI Community Implementation Awards; Hawaii Close

July 8, 1977